About Michael Bentley
Form D filings for Serina Therapeutics from 2012 to 2023 list Michael Bentley as executive officer and director.
Michael Bentley first appears on SEC filings in 2012.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Bentley in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Bentley works with at each company, as listed on that company's latest Form D.
Serina Therapeutics, Inc. · Form D, Mar 30, 2023
BF
Barbara Fisk
Director
JJ
James Hudson, Jr.
Director
RM
Randall Moreadith
Chief Executive Officer and President, director
SL
Steve Ledger
Director
GD
Greg Bailey, M.D.
Director
JH
J Harris
Executive officer and director
TV
Tacey Viegas
Executive officer